United States:
Episode 9 – John C. Ethridge, Jr. Partner | Corporate Practice | What Sets SGR Apart? (Podcast)
15 August 2020
Smith Gambrell & Russell
To print this article, all you need is to be registered or login on Mondaq.com.
Episode 9 – John C. Ethridge, Jr. Partner | Corporate
Practice | What Sets SGR Apart?
Originally published 13 August, 2020
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).